Oliva E, Carcangiu ML, Carinelli SG et alMesenchymal tumors. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH eds. WHO Classification of Tumours of Female Reproductive Organs 4th edn. International Agency for Research on Cancer: Lyon, France, 2014, pp 135–147.
Lee CH, Ou WB, Marino-Enriquez A et al. 14-3-3 Fusion oncogenes in high-grade endometrial stromal sarcoma. Proc Natl Acad Sci USA 2012;109:929–934.
Conklin CM, Longacre TA. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol 2014;21:383–393.
Lee CH, Marino-Enriquez A, Ou W et al. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am J Surg Pathol 2012;36:641–653.
Croce S, Hostein I, Ribeiro A et al. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations. Mod Pathol 2013;26:1390–1400.
Aisagbonhi O, Harrison B, Zhao L et al. YWHAE rearrangement in a purely conventional low-grade endometrial stromal sarcoma that transformed over time to high-grade sarcoma: importance of molecular testing. Int J Gynecol Pathol (in press); e-pub ahead of print.
Sciallis AP, Bedroske PP, Schoolmeester JK et al. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features. Am J Surg Pathol 2014;38:1161–1172.
Lee CH, Ali RH, Rouzbahman M et al. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Am J Surg Pathol 2012;36:1562–1570.
Chiang S, Lee CH, Stewart CJR et al. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod Pathol 2017;30:1251–1261.
Kruse AJ, Croce S, Kruitwagen RF et al. Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset. Int J Gynecol Pathol 2014;24:1616–1622.
Gremel G, Liew M, Hamzei F et al. A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival. Int J Cancer 2015;136:1608–1618.
Hoang LN, Aneja A, Conlon N et al. Novel high-grade endometrial stromal sarcoma: a morphologic mimicker of myxoid leiomyosarcoma. Am J Surg Pathol 2017;41:12–24.
Antonescu CR, Sung YS, Chen CL et al. Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors-molecular characterization shows genetic overlap with endometrial stromal sarcoma. Genes Chromosomes Cancer 2014;53:183–193.
Panagopoulos I, Thorsen J, Gorunova L et al. Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation. Genes Chromosomes Cancer 2013;52:610–618.
Cheng DT, Mitchell TN, Zehir A et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn 2015;17:251–264.
Kao YC, Sung YS, Zhang L et al. Recurrent BCOR internal tandem duplication and YWHAE-NUTM2B fusions in soft tissue undifferentiated round cell sarcoma of infancy: overlapping genetic features with clear cell sarcoma of kidney. Am J Surg Pathol 2016;40:1009–1020.
Zheng Z, Liebers M, Zhelyazkova B et al. Anchored multiplex PCR for targeted next-generation sequencing. Nat Med 2014;20:1479–1484.
Chiang S, Oliva E. Recent developments in uterine mesenchymal neoplasms. Histopathology 2013;62:124–137.
Goh R, Dal Cin P, Chiang S et al. Myxoid smooth muscle tumors of the uterus: clinicopathologic study of 40 cases. Mod Pathol 2016;29:285A.
Parra-Herran C, Schoolmeester JK, Yuan L et al. Myxoid leiomyosarcoma of the uterus: a clinicopathologic analysis of 30 cases and review of the literature with reappraisal of its distinction from other uterine myxoid mesenchymal neoplasms. Am J Surg Pathol 2016;40:285–301.
King ME, Dickersin GR, Scully RE. Myxoid leiomyosarcoma of the uterus. A report of six cases. Am J Surg Pathol 1982;6:589–598.
Gadducci A, Cosio S, Romanini A et al. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 2008;65:129–142.
Kurihara S, Oda Y, Ohishi Y et al. Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases. Am J Surg Pathol 2008;32:1228–1238.
Koontz JI, Soreng AL, Nucci M et al. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA 2001;98:6348–6353.
Pinto A, Howitt B. Uterine adenosarcoma. Arch Pathol Lab Med 2016;140:286–290.
Piscuoglio S, Burke KA, Ng CK et al. Uterine adenosarcomas are mesenchymal neoplasms. J Pathol 2016;238:381–388.
Parra-Herran C, Quick CM, Howitt BE et al. Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course. Am J Surg Pathol 2015;39:157–168.
Fuehrer NE, Keeney GL, Ketterling RP et al. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract. Arch Pathol Lab Med 2012;136:623–626.
Bennett JA, Nardi V, Rouzbahman M et al. Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum. Mod Pathol 2017;30:1489–1503.
Huynh KD, Fischle W, Verdin E et al. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev 2000;14:1810–1823.
Fan Z, Yamaza T, Lee JS et al. BCOR regulates mesenchymal stem cell function by epigenetic mechanisms. Nat Cell Biol 2009;11:1002–1009.
Ng D, Thakker N, Corcoran CM et al. Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR. Nat Genet 2004;36:411–416.
Grossmann V, Tiacci E, Holmes AB et al. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood 2011;118:6153–6163.
Lindsley RC, Mar BG, Mazzola E et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood 2015;125:1367–1376.
Damm F, Chesnais V, Nagata Y et al. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders. Blood 2013;122:3169–3177.
Dobashi A, Tsuyama N, Asaka R et al. Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type. Genes Chromosomes Cancer 2016;55:460–471.
Zhang J, Benavente CA, McEvoy J et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 2012;481:329–334.
Pugh TJ, Weeraratne SD, Archer TC et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 2012;488:106–110.
Sturm D, Orr BA, Toprak UH et al. New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 2016;164:1060–1072.
Shern JF, Chen L, Chmielecki J et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov 2014;4:216–231.
Astolfi A, Melchionda F, Perotti D et al. Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney. Oncotarget 2015;6:40934–40939.
Karlsson J, Valind A, Gisselsson D. BCOR internal tandem duplication and YWHAE-NUTM2B/E fusion are mutually exclusive events in clear cell sarcoma of the kidney. Genes Chromosomes Cancer 2016;55:120–123.
Ueno-Yokohata H, Okita H, Nakasato K et al. Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney. Nat Genet 2015;47:861–863.
Argani P, Kao YC, Zhang L et al. Primary renal sarcomas with BCOR-CCNB3 gene fusion: a report of 2 cases showing histologic overlap with clear cell sarcoma of kidney, suggesting further link between BCOR-related sarcomas of the kidney and soft tissues. Am J Surg Pathol 2017;41:1702–1712.
Specht K, Zhang L, Sung YS et al. Novel BCOR-MAML3 and ZC3H7B-BCOR gene fusions in undifferentiated small blue round cell sarcomas. Am J Surg Pathol 2016;40:433–442.
Peters TL, Kumar V, Polikepahad S et al. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod Pathol 2015;28:575–586.
Li WS, Liao IC, Wen MC et al. BCOR-CCNB3-positive soft tissue sarcoma with round-cell and spindle-cell histology: a series of four cases highlighting the pitfall of mimicking poorly differentiated synovial sarcoma. Histopathol 2016;69:792–801.